1Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?[J]. Lancet, 2001,357(9255): 539-545.
2Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011,144(5): 646-674.
3Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
4Liu Q, Li G, Li R, et al. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines [J]. J Neurooncol, 2010, 100(2): 165-176.
5Li R, Li G, Deng L, et al. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1 [J]. Oncol Rep, 2010, 23(6): 1553-1559.
6Rempel SA, Dudas S, Ge S, et al. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma [J]. Clin Cancer Res, 2000, 6(1): 102-111.
7Salmaggi A, Gelati M, Polio B, et al. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells [J]. J Neurooncol, 2004, 67 (3): 305 -317.
8Calatozzolo C, Madema E, Polio B, et al. Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas[J]. Cancer Biol Ther, 2006, 5(7): 827-832.
9Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors [J]. Proc Natl Acad Sci U S A, 2003, 100(23): 13513-13518.
10Erreni M, Solinas G, Brescia P, et al. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CRl[J]. Eur J Cancer, 2010, 46(18): 3383-3392.
二级参考文献14
1KAMAL R, JINDAL A, SURI A, et al. Effect of craniopharyngioma fluid on femoral vessels of rat [ J ], Neurol Res, 1999,21 (8) : 796 -798.
2NISHIOKA H, ITO H, HARAOKA J, et al. Repeated hemorrhage in ciliated craniopharyngioma - case report[J]. Neurol Med Chir, 2000,40(6) :324 - 328.
3NISHIOKA H,ITO H,HARAOKA J,et al.Repeated hemorrhage in ciliated craniopharyngioma-case report[J].Neurol Med Chir,2000,40(6):324-328.
4TAPHOORN M J,VANES C,GOOSKENS R H,et al.Children with craniopharyngioma,a"benign"brain tumor with a high morbidity[J].Ned Tijdschr Geneeskd,2000,144(36):1705-1709.
5ROMERO I A,AMOS C L,GREENWOOD J,et al.Ezrin and moesin co-localise with ICAM - 1 in brain endothelial cells but are not directly associated[J].Brain Res Mol Brain Res,2002,105(1):47-59.2002,105(1):47- 59.
6Im SH,Wang KC,Kim SK,et al.Transsphenoidal microsurgery for pediatric craniopharyngioma:special considerations regarding indications and method[J].Pediatr Neurosurg,2003,39(2):97-103.
7Reyes F.Craniopharyngioma.Recurrence[J].An R Acad Nac Med (Madr),2001,118 (2):263-73.
8Spertini F,Perret-Menoud V,Barbier N,et al.Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells[J].Immunology,2004,113(4):441-52.
9John M,Duff,M,Fredric B,et al.Long-term outcomes for surgically resected craniopharyngiomas[J].Neurosurgery,2000,46(2):291-305.
10Adamson TE,Wiestler OD,Kleihues P,et al.Correlation of clinical and pathological features in surgically treated craniopharyngiomas[J].J Neurosurg,1990,73(1):12-7.
